Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions
- 24 March 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (12), 4917-4922
- https://doi.org/10.1073/pnas.0811586106
Abstract
Heroin remains a major drug of abuse and is preferred by addicts over morphine. Like morphine, heroin has high affinity and selectivity for μ-receptors, but its residual analgesia in exon 1 MOR-1 knockout mice that do not respond to morphine suggests a different mechanism of action. MOR-1 splice variants lacking exon 1 have been observed in mice, humans, and rats, raising the possibility that they might be responsible for the residual heroin and morphine-6β-glucuronide (M6G) analgesia in the exon 1 knockout mice. To test this possibility, we disrupted exon 11 of MOR-1, which eliminates all of the variants that do not contain exon 1. Morphine and methadone analgesia in the exon 11 knockout mouse was normal, but the analgesic actions of heroin, M6G, and fentanyl were markedly diminished in the radiant heat tail-flick and hot-plate assays. Similarly, the ability of M6G to inhibit gastrointestinal transit was greatly diminished in these exon 11 knockout mice, whereas the ability of morphine was unchanged. These findings identify receptors selectively involved with heroin and M6G actions and confirm the relevance of the exon 11-associated variants and raise important issues regarding the importance of atypical truncated G-protein-coupled receptors.Keywords
This publication has 28 references indexed in Scilit:
- Isolation and characterization of new exon 11‐associated N‐terminal splice variants of the human mu opioid receptor geneJournal of Neurochemistry, 2009
- Identification of Four Novel Exon 5 Splice Variants of the Mouse μ-Opioid Receptor Gene: Functional Consequences of C-Terminal SplicingMolecular Pharmacology, 2005
- Functional analysis of MOR‐1 splice variants of the mouse mu opioid receptor gene OprmSynapse, 2003
- Synergy between μ Opioid Ligands: Evidence for Functional Interactions among μ Opioid Receptor SubtypesJournal of Pharmacology and Experimental Therapeutics, 2002
- Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor geneNature, 1996
- Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesiaNeuroscience Letters, 1996
- Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptorFEBS Letters, 1995
- Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptorLife Sciences, 1994
- The effect of a vitamin e-deficient diet on amino acid levels in the substantia nigra, striatum and hippocampus of ratsLife Sciences, 1994
- Expression of two variants of the human μ opioid receptor mRNA in SK‐N‐SH cells and human brainFEBS Letters, 1994